These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38878151)

  • 1. PharmacoEconomics Supplement : Advancing methods to measure and reward healthcare innovation: results from the valuing innovation project.
    Pharmacoeconomics; 2024 Jul; 42(Suppl 2):181. PubMed ID: 38878151
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of pharmacoepidemiology and pharmacoeconomics in promoting access and stimulating innovation.
    Avorn J
    Pharmacoeconomics; 2004; 22(2 Suppl 2):81-6. PubMed ID: 15660480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoeconomics and immunotherapy.
    Berto P
    Eur Ann Allergy Clin Immunol; 2007; 39 Spec No():12-6. PubMed ID: 18924461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PharmacoEconomics. Foreword.
    Milne CP
    Pharmacoeconomics; 2006 Dec; 24 Suppl 2():1-3. PubMed ID: 23389483
    [No Abstract]   [Full Text] [Related]  

  • 5. Barriers to implementing pharmacoeconomics: interview study.
    Alefan Q; Hamdouni E; Alhamad H; Mukattash T; Rascati K
    Expert Rev Pharmacoecon Outcomes Res; 2021 Feb; 21(1):93-104. PubMed ID: 32394752
    [No Abstract]   [Full Text] [Related]  

  • 6. The value of innovation in decision-making in health care in Central Eastern Europe - The Sixth International Conference, 2 June 2017, Belgrade, Serbia.
    Novakovic T; Martin AP; Parker M; Ferrario A; Vukovic S; Łanda K; Duba J; Dankó D; Kotsopoulos N; Godman B; Ristic J; Stefanovic D; Tesic D
    Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):519-521. PubMed ID: 28946800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacoeconomic picture in Saudi Arabia.
    Alkhenizan A
    Expert Rev Pharmacoecon Outcomes Res; 2014 Aug; 14(4):483-90. PubMed ID: 24953076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacoeconomics in the new millennium. A pharmaceutical industry perspective.
    Thwaites R; Townsend RJ
    Pharmacoeconomics; 1998 Feb; 13(2):175-80. PubMed ID: 10178645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacoeconomics and policy decisions: the Australian health care system.
    Henry D; Lopert R
    Clin Ther; 1999 May; 21(5):909-15. PubMed ID: 10397384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PharmacoEconomics Supplement : Advancing measurement of children's health-related quality of life - evidence from the QUOKKA (QUality OF Life in Kids: Key evidence to strengthen decisions in Australia) research program.
    Pharmacoeconomics; 2024 Jun; 42(Suppl 1):1. PubMed ID: 38722541
    [No Abstract]   [Full Text] [Related]  

  • 11. [Health economics: should it concern the health sector?].
    Collazo Herrera M; Cárdenas Rodríguez J; González López R; Miyar Abreu R; Gálvez González AM; Cosme Casulo J
    Rev Panam Salud Publica; 2002 Nov; 12(5):359-65. PubMed ID: 12587229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness regulations and pharmaceutical innovation.
    Vernon JA; Golec JH; Stevens JS
    Pharmacoeconomics; 2010; 28(10):877-87. PubMed ID: 20831295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advancing Methods to Measure and Reward Healthcare Innovation.
    Chapman R; Xie R
    Pharmacoeconomics; 2024 Jul; 42(Suppl 2):183-185. PubMed ID: 38914875
    [No Abstract]   [Full Text] [Related]  

  • 14. Improving health care outcomes through reallocation of health care expenditures.
    Langley PC
    Clin Ther; 1997; 19(5):1092-100. PubMed ID: 9385496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of innovation and insurance coverage on price elasticity of demand for prescription drugs: some empirical lessons in pharmacoeconomics.
    Mendoza RL
    J Med Econ; 2020 Sep; 23(9):915-922. PubMed ID: 32432950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacoeconomics in contemporary medicine].
    Czech M
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():16-9. PubMed ID: 15524007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacoeconomics - Challenges for Health Professionals].
    Turčić P; Benković V; Brborović O; Valent A
    Acta Med Croatica; 2016 Apr; 70(2):117-23. PubMed ID: 28722840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the quality of the websites of pharmacoeconomics and health economics centers through a validated questionnaire].
    Domínguez-Castro A; Iñesta-García A
    Gac Sanit; 2004; 18(4):295-304. PubMed ID: 15324640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value-based approaches to healthcare systems and pharmacoeconomics requirements in Asia: South Korea, Taiwan, Thailand and Japan.
    Kamae I
    Pharmacoeconomics; 2010; 28(10):831-8. PubMed ID: 20831290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers and Facilitators of Pharmacoeconomic Studies: A Review of Evidence from the Middle Eastern Countries.
    Alzarea AI; Khan YH; Alanazi AS; Butt MH; Almalki ZS; AlAhmari AK; Alsahali S; Mallhi TH
    Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.